Fatigue - Pipeline Review, H2 2018

  • ID: 4590333
  • Drug Pipelines
  • 38 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • Chronos Therapeutics Ltd
  • K-Pax Pharmaceuticals Inc
  • Resolys Bio Inc
  • MORE
Fatigue - Pipeline Review, H2 2018

Summary:

This latest Pharmaceutical and Healthcare disease pipeline guide Fatigue - Pipeline Review, H2 2018, provides an overview of the Fatigue (Central Nervous System) pipeline landscape.

Fatigue also referred to as tiredness, exhaustion, lethargy, listlessness, and describes a physical and/or mental state of being tired and weak. Signs and symptoms include aching or sore muscles, painful lymph nodes, chronic (long-term) tiredness, dizziness, headache, irritability and loss of appetite.

Report Highlights:

This latest pipeline guide Fatigue - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Fatigue (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Fatigue (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Fatigue and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Unknown stages are 3, 1, 2 and 2 respectively.

Fatigue (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Fatigue (Central Nervous System).
  • The pipeline guide reviews pipeline therapeutics for Fatigue (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Fatigue (Central Nervous System) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Fatigue (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Fatigue (Central Nervous System)
Reasons for Purchase:
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Fatigue (Central Nervous System).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Fatigue (Central Nervous System) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Chronos Therapeutics Ltd
  • K-Pax Pharmaceuticals Inc
  • Resolys Bio Inc
  • MORE
Introduction

Report Coverage

Fatigue - Overview

Fatigue - Therapeutics Development

Pipeline Overview

Pipeline by Companies

Products under Development by Companies

Fatigue - Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Fatigue - Companies Involved in Therapeutics Development

Aoxing Pharmaceutical Company Inc

Chronos Therapeutics Ltd

K-Pax Pharmaceuticals Inc

Merz Pharma GmbH & Co KgaA

MultiCell Technologies Inc

Resolys Bio Inc

Fatigue - Drug Profiles

(lofepramine hydrochloride + phenylalanine) - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

anamorelin hydrochloride - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Biologic for Chronic Pain and Fatigue - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

caffeine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

CTDP-001 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

KPAX-002 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

MRZ-9547 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

phenylbutyrate - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Fatigue - Dormant Projects

Fatigue - Product Development Milestones

Featured News & Press Releases

Jun 14, 2010: MultiCell Retains CDSS To Manage MCT-125 Phase IIb Clinical Trial For PMSF In UK

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Number of Products under Development for Fatigue, H2 2018

Number of Products under Development by Companies, H2 2018

Products under Development by Companies, H2 2018

Number of Products by Stage and Target, H2 2018

Number of Products by Stage and Mechanism of Action, H2 2018

Number of Products by Stage and Route of Administration, H2 2018

Number of Products by Stage and Molecule Type, H2 2018

Fatigue - Pipeline by Aoxing Pharmaceutical Company Inc, H2 2018

Fatigue - Pipeline by Chronos Therapeutics Ltd, H2 2018

Fatigue - Pipeline by K-Pax Pharmaceuticals Inc, H2 2018

Fatigue - Pipeline by Merz Pharma GmbH & Co KgaA, H2 2018

Fatigue - Pipeline by MultiCell Technologies Inc, H2 2018

Fatigue - Pipeline by Resolys Bio Inc, H2 2018

Fatigue - Dormant Projects, H2 2018

List of Figures

Number of Products under Development for Fatigue, H2 2018

Number of Products under Development by Companies, H2 2018

Number of Products by Targets, H2 2018

Number of Products by Stage and Targets, H2 2018

Number of Products by Mechanism of Actions, H2 2018

Number of Products by Stage and Mechanism of Actions, H2 2018

Number of Products by Routes of Administration, H2 2018

Number of Products by Stage and Routes of Administration, H2 2018

Number of Products by Molecule Types, H2 2018

Number of Products by Stage and Molecule Types, H2 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Aoxing Pharmaceutical Company Inc
  • Chronos Therapeutics Ltd
  • K-Pax Pharmaceuticals Inc
  • Merz Pharma GmbH & Co KgaA
  • MultiCell Technologies Inc
  • Resolys Bio Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll